BBVA USA Bancshares Inc. lifted its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 3.9% during the third quarter, Holdings Channel.com reports. The firm owned 49,029 shares of the medical equipment provider’s stock after acquiring an additional 1,834 shares during the quarter. BBVA USA Bancshares Inc.’s holdings in Smith & Nephew were worth $2,360,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Whittier Trust Co. acquired a new position in shares of Smith & Nephew during the third quarter worth $26,000. LS Investment Advisors LLC acquired a new position in shares of Smith & Nephew during the second quarter worth $31,000. AdvisorNet Financial Inc lifted its holdings in shares of Smith & Nephew by 82.4% during the third quarter. AdvisorNet Financial Inc now owns 664 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 300 shares during the period. Advisory Services Network LLC lifted its holdings in shares of Smith & Nephew by 132.7% during the second quarter. Advisory Services Network LLC now owns 819 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 467 shares during the period. Finally, Oakworth Capital Inc. acquired a new position in shares of Smith & Nephew during the second quarter worth $42,000. Institutional investors own 9.11% of the company’s stock.
A number of equities analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a report on Saturday, November 2nd. ValuEngine downgraded shares of Smith & Nephew from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. Sanford C. Bernstein began coverage on shares of Smith & Nephew in a research note on Tuesday. They set an “outperform” rating for the company. Finally, Berenberg Bank raised shares of Smith & Nephew from a “hold” rating to a “buy” rating in a research note on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. Smith & Nephew currently has a consensus rating of “Hold” and a consensus target price of $27.50.
Shares of NYSE SNN opened at $42.26 on Wednesday. Smith & Nephew plc has a twelve month low of $35.39 and a twelve month high of $48.93. The firm has a fifty day simple moving average of $45.52 and a 200 day simple moving average of $44.50. The company has a market capitalization of $18.59 billion, a PE ratio of 20.92, a P/E/G ratio of 3.80 and a beta of 0.23. The company has a quick ratio of 0.96, a current ratio of 2.00 and a debt-to-equity ratio of 0.40.
The company also recently announced a — dividend, which was paid on Wednesday, October 30th. Investors of record on Friday, October 4th were paid a dividend of $0.288 per share. This represents a yield of 1.5%. The ex-dividend date of this dividend was Thursday, October 3rd. Smith & Nephew’s dividend payout ratio is presently 27.72%.
Smith & Nephew Company Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Recommended Story: Why Invest in Dividend Achievers?
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.